Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000124111 | SCV000050811 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000124111 | SCV000167520 | benign | not specified | 2011-07-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000124111 | SCV000225950 | benign | not specified | 2015-03-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000124111 | SCV000317158 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000253056 | SCV000317858 | benign | Cardiovascular phenotype | 2015-04-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000860347 | SCV001000374 | benign | Brugada syndrome 4 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004717995 | SCV005320485 | benign | not provided | criteria provided, single submitter | not provided |